Business

We are promoting human health through innovative medicine development

R&D

R&D pipeline

Research / Pre-Clinical

Clinical Development

Registration / Post-Launch

Lifecycle
Management

SKP-0120
Subcutaneous immunoglobulin 20%

SKP-0110
Intravenous immunoglobulin 10%

SKP-0100
Intravenous immunoglobulin 5%

SKP-0130
Albumin 5, 20%

SKP-0140
Haemophilia A

New Product
Development

SKP-0150
Haemophilia B

SKP-0160
Hemostasis

Haemophilia
A & B

SKP-0190
Obesity

SKP-0180
Haemophilia A

상단으로 이동